Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2024 Filed Feb 20, 2024 16:41 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 30,223 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-24-000045 · wk-form4_1708465261.xml · derivative · entry 3 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,223 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Restricted Stock Units vested on February 15, 2024 and were part of a grant made to the reporting person on February 18, 2020. The vested shares were delivered to the reporting person on the vesting date. F3 · derivative.expiration_date: The Restricted Stock Units vested on February 15, 2024 and were part of a grant made to the reporting person on February 18, 2020. The vested shares were delivered to the reporting person on the vesting date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 16:41 UTC |
SANYAL SUNNYDirector · President and CEO
|
Tax withholdingCommon Stock | 13,520 | $17.40 | $235,248.00 |
DisclosureSEC source: 0001681622-24-000045 · wk-form4_1708465261.xml · nonDerivative · entry 2 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,304 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 16:41 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionCommon Stock | 30,223 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-24-000045 · wk-form4_1708465261.xml · nonDerivative · entry 1 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,824 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 21:40 UTC |
Hartmann AndrewSVP and GM, Detectors
|
Exercise / conversionRestricted Stock Units · Derivative | 5,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-24-000043 · wk-form4_1708465198.xml · derivative · entry 3 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,135 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Restricted Stock Units vested on February 15, 2024 and were part of a grant made to the reporting person on February 18, 2020. The vested shares were delivered to the reporting person on the vesting date. F3 · derivative.expiration_date: The Restricted Stock Units vested on February 15, 2024 and were part of a grant made to the reporting person on February 18, 2020. The vested shares were delivered to the reporting person on the vesting date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 21:40 UTC |
Hartmann AndrewSVP and GM, Detectors
|
Tax withholdingCommon Stock | 2,429 | $17.40 | $42,264.60 |
DisclosureSEC source: 0001681622-24-000043 · wk-form4_1708465198.xml · nonDerivative · entry 2 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,388 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 21:40 UTC |
Hartmann AndrewSVP and GM, Detectors
|
Exercise / conversionCommon Stock | 5,135 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-24-000043 · wk-form4_1708465198.xml · nonDerivative · entry 1 Hartmann Andrew · CIK 0001846805 · SVP and GM, Detectors 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 11, 2024 Filed Feb 12, 2024 22:03 UTC |
Rosebrough Walter M JrDirector
|
Exercise / conversionDeferred Stock Units · Derivative | 6,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-24-000021 · wk-form4_1707775376.xml · derivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,881 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vested on February 11, 2022. There was an inadvertent discrepancy in the originally filed Form 4 that showed that vested shares would be delivered to the reporting person on the earlier of (i) the 2024 Annual Meeting, (ii) a change in control, or (iii) the reporting person's termination of service for any reason. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 11, 2024, the third anniversary of the grant date. F3 · derivative.expiration_date: These Deferred Stock Units vested on February 11, 2022. There was an inadvertent discrepancy in the originally filed Form 4 that showed that vested shares would be delivered to the reporting person on the earlier of (i) the 2024 Annual Meeting, (ii) a change in control, or (iii) the reporting person's termination of service for any reason. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 11, 2024, the third anniversary of the grant date. Read SEC document |
| February 11, 2024 Filed Feb 12, 2024 22:03 UTC |
Rosebrough Walter M JrDirector
|
Exercise / conversionCommon Stock | 6,881 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-24-000021 · wk-form4_1707775376.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,742 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 11, 2024 Filed Feb 12, 2024 22:04 UTC |
TSINGOS CHRISTINE ADirector
|
Exercise / conversionDeferred Stock Units · Derivative | 6,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-24-000024 · wk-form4_1707775445.xml · derivative · entry 3 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,881 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vested on February 11, 2022. There was an inadvertent discrepancy in the originally filed Form 4 that showed that vested shares would be delivered to the reporting person on the earlier of (i) the 2024 Annual Meeting, (ii) a change in control, or (iii) the reporting person's termination of service for any reason. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 11, 2024, the third anniversary of the grant date. F3 · derivative.expiration_date: These Deferred Stock Units vested on February 11, 2022. There was an inadvertent discrepancy in the originally filed Form 4 that showed that vested shares would be delivered to the reporting person on the earlier of (i) the 2024 Annual Meeting, (ii) a change in control, or (iii) the reporting person's termination of service for any reason. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 11, 2024, the third anniversary of the grant date. Read SEC document |
| February 11, 2024 Filed Feb 12, 2024 22:04 UTC |
TSINGOS CHRISTINE ADirector
|
Exercise / conversionCommon Stock | 6,881 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-24-000024 · wk-form4_1707775445.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,599 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 11, 2024 Filed Feb 12, 2024 17:03 UTC |
GUERTIN TIMOTHY EDirector
|
Exercise / conversionDeferred Stock Units · Derivative | 6,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-24-000022 · wk-form4_1707775392.xml · derivative · entry 3 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,881 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vested on February 11, 2022. There was an inadvertent discrepancy in the originally filed Form 4 that showed that vested shares would be delivered to the reporting person on the earlier of (i) the 2024 Annual Meeting, (ii) a change in control, or (iii) the reporting person's termination of service for any reason. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 11, 2024, the third anniversary of the grant date. F3 · derivative.expiration_date: These Deferred Stock Units vested on February 11, 2022. There was an inadvertent discrepancy in the originally filed Form 4 that showed that vested shares would be delivered to the reporting person on the earlier of (i) the 2024 Annual Meeting, (ii) a change in control, or (iii) the reporting person's termination of service for any reason. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 11, 2024, the third anniversary of the grant date. Read SEC document |
| February 11, 2024 Filed Feb 12, 2024 17:03 UTC |
GUERTIN TIMOTHY EDirector
|
Exercise / conversionCommon Stock | 6,881 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-24-000022 · wk-form4_1707775392.xml · nonDerivative · entry 1 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 11, 2024 Filed Feb 12, 2024 17:04 UTC |
Kunkel Jay K.Director
|
Exercise / conversionDeferred Stock Units · Derivative | 6,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-24-000023 · wk-form4_1707775423.xml · derivative · entry 3 Kunkel Jay K. · CIK 0001592005 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,881 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vested on February 11, 2022. There was an inadvertent discrepancy in the originally filed Form 4 that showed that vested shares would be delivered to the reporting person on the earlier of (i) the 2024 Annual Meeting, (ii) a change in control, or (iii) the reporting person's termination of service for any reason. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 11, 2024, the third anniversary of the grant date. F3 · derivative.expiration_date: These Deferred Stock Units vested on February 11, 2022. There was an inadvertent discrepancy in the originally filed Form 4 that showed that vested shares would be delivered to the reporting person on the earlier of (i) the 2024 Annual Meeting, (ii) a change in control, or (iii) the reporting person's termination of service for any reason. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 11, 2024, the third anniversary of the grant date. Read SEC document |
| February 11, 2024 Filed Feb 12, 2024 17:04 UTC |
Kunkel Jay K.Director
|
Exercise / conversionCommon Stock | 6,881 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-24-000023 · wk-form4_1707775423.xml · nonDerivative · entry 1 Kunkel Jay K. · CIK 0001592005 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,479 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 11, 2024 Filed Feb 12, 2024 22:05 UTC |
Chertoff Jocelyn DDirector
|
Exercise / conversionDeferred Stock Units · Derivative | 6,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-24-000026 · wk-form4_1707775484.xml · derivative · entry 3 Chertoff Jocelyn D · CIK 0001701927 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,881 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vested on February 11, 2022. There was an inadvertent discrepancy in the originally filed Form 4 that showed that vested shares would be delivered to the reporting person on the earlier of (i) the 2024 Annual Meeting, (ii) a change in control, or (iii) the reporting person's termination of service for any reason. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 11, 2024, the third anniversary of the grant date. F3 · derivative.expiration_date: These Deferred Stock Units vested on February 11, 2022. There was an inadvertent discrepancy in the originally filed Form 4 that showed that vested shares would be delivered to the reporting person on the earlier of (i) the 2024 Annual Meeting, (ii) a change in control, or (iii) the reporting person's termination of service for any reason. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 11, 2024, the third anniversary of the grant date. Read SEC document |
| February 11, 2024 Filed Feb 12, 2024 22:05 UTC |
Chertoff Jocelyn DDirector
|
Exercise / conversionCommon Stock | 6,881 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-24-000026 · wk-form4_1707775484.xml · nonDerivative · entry 1 Chertoff Jocelyn D · CIK 0001701927 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,138 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 22:03 UTC |
Rosebrough Walter M JrDirector
|
GrantDeferred Stock Units · Derivative | 11,689 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-24-000021 · wk-form4_1707775376.xml · derivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,689 Underlying: Common Shares · 11,689 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 22:04 UTC |
TSINGOS CHRISTINE ADirector
|
GrantDeferred Stock Units · Derivative | 9,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-24-000024 · wk-form4_1707775445.xml · derivative · entry 2 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,643 Underlying: Common Stock · 9,643 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 17:03 UTC |
GUERTIN TIMOTHY EDirector
|
GrantDeferred Stock Units · Derivative | 9,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-24-000022 · wk-form4_1707775392.xml · derivative · entry 2 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,643 Underlying: Common Stock · 9,643 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 17:04 UTC |
Bardwell KathleenDirector
|
GrantDeferred Stock Units · Derivative | 9,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-24-000025 · wk-form4_1707775464.xml · derivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,643 Underlying: Common Stock · 9,643 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 17:04 UTC |
Kunkel Jay K.Director
|
GrantDeferred Stock Units · Derivative | 9,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-24-000023 · wk-form4_1707775423.xml · derivative · entry 2 Kunkel Jay K. · CIK 0001592005 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,643 Underlying: Common Stock · 9,643 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 22:05 UTC |
Chertoff Jocelyn DDirector
|
GrantDeferred Stock Units · Derivative | 9,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-24-000026 · wk-form4_1707775484.xml · derivative · entry 2 Chertoff Jocelyn D · CIK 0001701927 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,643 Underlying: Common Stock · 9,643 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 17:54 UTC |
Honeysett Kimberley E.SVP and General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 5,108 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-23-000087 · wk-form4_1702421662.xml · derivative · entry 5 Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,108 Underlying: Common Stock · 5,108 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 17:54 UTC |
Honeysett Kimberley E.SVP and General Counsel
|
GrantRestricted Stock Units · Derivative | 17,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-23-000087 · wk-form4_1702421662.xml · derivative · entry 4 Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,140 Underlying: Common Stock · 17,140 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2023 vest 50% on December 10, 2025 and 50% on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2023 vest 50% on December 10, 2025 and 50% on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 17:54 UTC |
Honeysett Kimberley E.SVP and General Counsel
|
Tax withholdingCommon Stock | 2,248 | $19.69 | $44,263.12 |
DisclosureSEC source: 0001681622-23-000087 · wk-form4_1702421662.xml · nonDerivative · entry 2 Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,860 F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 17:54 UTC |
Honeysett Kimberley E.SVP and General Counsel
|
Exercise / conversionCommon Stock | 5,108 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-23-000087 · wk-form4_1702421662.xml · nonDerivative · entry 1 Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On December 10, 2021, the Reporting Person was granted 10,216 Restricted Stock Units, 50% of which vested on December 10, 2023 and 50% of which vest on December 10, 2025. F2 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 17:55 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Exercise / conversionRestricted Stock Units · Derivative | 4,664 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-23-000089 · wk-form4_1702421701.xml · derivative · entry 4 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,664 Underlying: Common Stock · 4,664 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F6 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 17:55 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
GrantRestricted Stock Units · Derivative | 15,871 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-23-000089 · wk-form4_1702421701.xml · derivative · entry 3 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,742 Underlying: Common Stock · 15,871 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2023 vest 50% on December 10, 2025 and 50% on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2023 vest 50% on December 10, 2025 and 50% on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 17:55 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Tax withholdingCommon Stock | 2,053 | $19.69 | $40,423.57 |
DisclosureSEC source: 0001681622-23-000089 · wk-form4_1702421701.xml · nonDerivative · entry 2 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,826 F4 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 17:55 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Exercise / conversionCommon Stock | 4,664 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-23-000089 · wk-form4_1702421701.xml · nonDerivative · entry 1 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On December 10, 2021, the Reporting Person was granted 9,328 Restricted Stock Units, 50% of which vested on December 10, 2023 and 50% of which vest on December 10, 2025. F2 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 1,173 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 17:54 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 26,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-23-000085 · wk-form4_1702421631.xml · derivative · entry 4 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,652 Underlying: Common Stock · 26,652 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F6 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2021 vested 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2021 vested 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 17:54 UTC |
SANYAL SUNNYDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 95,226 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-23-000085 · wk-form4_1702421631.xml · derivative · entry 3 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,226 Underlying: Common Stock · 95,226 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2023 vest 50% on December 10, 2025 and 50% on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2023 vest 50% on December 10, 2025 and 50% on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 17:54 UTC |
SANYAL SUNNYDirector · President and CEO
|
Tax withholdingCommon Stock | 11,727 | $19.69 | $230,904.63 |
DisclosureSEC source: 0001681622-23-000085 · wk-form4_1702421631.xml · nonDerivative · entry 2 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,601 F4 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 17:54 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionCommon Stock | 26,652 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-23-000085 · wk-form4_1702421631.xml · nonDerivative · entry 1 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,328 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On December 10, 2021, the Reporting Person was granted 53,304 Restricted Stock Units, 50% of which vested on December 10, 2023 and 50% of which vest on December 10, 2025. F2 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 1,388 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 17:54 UTC |
Maheshwari ShubhamChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 7,062 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-23-000088 · wk-form4_1702421684.xml · derivative · entry 4 Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,063 Underlying: Common Stock · 7,062 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F6 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 17:54 UTC |
Maheshwari ShubhamChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 27,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-23-000088 · wk-form4_1702421684.xml · derivative · entry 3 Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,932 Underlying: Common Stock · 27,932 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2023 vest 50% on December 10, 2025 and 50% on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2023 vest 50% on December 10, 2025 and 50% on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 17:54 UTC |
Maheshwari ShubhamChief Financial Officer
|
Tax withholdingCommon Stock | 1,766 | $19.69 | $34,772.54 |
DisclosureSEC source: 0001681622-23-000088 · wk-form4_1702421684.xml · nonDerivative · entry 2 Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,780 F4 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 17:54 UTC |
Maheshwari ShubhamChief Financial Officer
|
Exercise / conversionCommon Stock | 7,062 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-23-000088 · wk-form4_1702421684.xml · nonDerivative · entry 1 Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On December 10, 2021, the Reporting Person was granted 14,125 Restricted Stock Units, 50% of which vested on December 10, 2023 and 50% of which vest on December 10, 2025. F2 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 1 share purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 22:54 UTC |
Hartmann AndrewSVP Sales & Marketing, Medical
|
Exercise / conversionRestricted Stock Units · Derivative | 4,664 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-23-000086 · wk-form4_1702421647.xml · derivative · entry 4 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,664 Underlying: Common Stock · 4,664 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 22:54 UTC |
Hartmann AndrewSVP Sales & Marketing, Medical
|
GrantRestricted Stock Units · Derivative | 15,871 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-23-000086 · wk-form4_1702421647.xml · derivative · entry 3 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,742 Underlying: Common Stock · 15,871 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2023 vest 50% on December 10, 2025 and 50% on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2023 vest 50% on December 10, 2025 and 50% on December 10, 2027. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 22:54 UTC |
Hartmann AndrewSVP Sales & Marketing, Medical
|
Tax withholdingCommon Stock | 1,959 | $19.69 | $38,572.71 |
DisclosureSEC source: 0001681622-23-000086 · wk-form4_1702421647.xml · nonDerivative · entry 2 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,682 F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| December 10, 2023 Filed Dec 12, 2023 22:54 UTC |
Hartmann AndrewSVP Sales & Marketing, Medical
|
Exercise / conversionCommon Stock | 4,664 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-23-000086 · wk-form4_1702421647.xml · nonDerivative · entry 1 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On December 10, 2021, the Reporting Person was granted 9,328 Restricted Stock Units, 50% of which vested on December 10, 2023 and 50% of which vest on December 10, 2025. F2 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| November 22, 2023 Filed Nov 27, 2023 16:43 UTC |
Honeysett Kimberley E.SVP and General Counsel
|
SaleCommon Stock | 6,174 | $19.72 | $121,751.28 |
DisclosureSEC source: 0001681622-23-000079 · wk-form4_1701121397.xml · nonDerivative · entry 1 Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Includes 261 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan since the last Form 4 filing of the reporting person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.67 to $19.77. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| June 16, 2023 Filed Jun 20, 2023 18:29 UTC |
Honeysett Kimberley E.SVP and General Counsel
|
SaleCommon Stock | 2,909 | $23.20 | $67,488.80 |
DisclosureSEC source: 0001681622-23-000058 · wf-form4_168730012520179.xml · nonDerivative · entry 1 Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,913 F1 · price: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Mar 17, 2023. All shares were sold at $23.20 F2 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 252 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan since the last Form 4 filing of the reporting person. Read SEC document |
| May 15, 2023 Filed May 17, 2023 16:32 UTC |
Maheshwari ShubhamChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,689 | $22.32 | $82,338.48 |
DisclosureSEC source: 0001681622-23-000052 · wf-form4_168435553349657.xml · derivative · entry 3 Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,689 Underlying: Common Stock · 3,689 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F1 · derivative.exercise_date: On May 21, 2021, the Reporting Person was granted 7,378 Restricted Stock Units, 50% of which vested on May 15, 2023 and 50% of which vest on May 15, 2025. F1 · derivative.expiration_date: On May 21, 2021, the Reporting Person was granted 7,378 Restricted Stock Units, 50% of which vested on May 15, 2023 and 50% of which vest on May 15, 2025. Read SEC document |
| May 15, 2023 Filed May 17, 2023 16:32 UTC |
Maheshwari ShubhamChief Financial Officer
|
Tax withholdingCommon Stock | 919 | $22.32 | $20,512.08 |
DisclosureSEC source: 0001681622-23-000052 · wf-form4_168435553349657.xml · nonDerivative · entry 2 Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,483 F4 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| May 15, 2023 Filed May 17, 2023 16:32 UTC |
Maheshwari ShubhamChief Financial Officer
|
Exercise / conversionCommon Stock | 3,689 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-23-000052 · wf-form4_168435553349657.xml · nonDerivative · entry 1 Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On May 21, 2021, the Reporting Person was granted 7,378 Restricted Stock Units, 50% of which vested on May 15, 2023 and 50% of which vest on May 15, 2025. F2 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · balance_after: Amount of securities beneficially owned at the end of the reporting period reflects 1,173 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document |
| May 08, 2023 Filed May 10, 2023 18:20 UTC |
Kunkel Jay K.Director
|
SaleCommon Stock | 9,120 | $21.90 | $199,728.00 |
DisclosureSEC source: 0001681622-23-000050 · wf-form4_168375721171014.xml · nonDerivative · entry 1 Kunkel Jay K. · CIK 0001592005 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,598 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.90 to $21.92. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 17:13 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
Exercise / conversionRestricted Stock Units · Derivative | 5,761 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-23-000038 · wf-form4_167667196280465.xml · derivative · entry 5 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,762 Underlying: Common Stock · 5,761 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units granted on February 16, 2021 vest 50% on February 15, 2023 and 50% on February 15, 2025. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units granted on February 16, 2021 vest 50% on February 15, 2023 and 50% on February 15, 2025. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 17:13 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
Exercise / conversionRestricted Stock Units · Derivative | 1,420 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-23-000038 · wf-form4_167667196280465.xml · derivative · entry 4 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,420 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.